Nicholas J. Veomett, Ph.D.

2014 Weill Cornell Medical College, New York, NY, United States 
Pharmacology, Oncology, Immunology
"Nicholas Veomett"
Mean distance: (not calculated yet)


Sign in to add mentor
David A. Scheinberg grad student 2014 Weill Cornell Medical College
 (Regulating the therapeutic efficacy of a TCR-like antibody to intracellular WT1 via FC engineering and target modulation.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dao T, Pankov D, Scott A, et al. (2015) Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature Biotechnology
Veomett N, Dao T, Liu H, et al. (2014) Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4036-46
Veomett N, Dao T, Scheinberg DA. (2013) Therapeutic antibodies to intracellular targets in cancer therapy. Expert Opinion On Biological Therapy. 13: 1485-8
Mallikaratchy P, Gardner J, Nordstrøm LU, et al. (2013) A self-assembling short oligonucleotide duplex suitable for pretargeting. Nucleic Acid Therapeutics. 23: 289-99
Dao T, Yan S, Veomett N, et al. (2013) Targeting the intracellular WT1 oncogene product with a therapeutic human antibody. Science Translational Medicine. 5: 176ra33
Dubrovsky L, Brea EJ, Veomett NJ, et al. (2013) Therapeutic superiority of a TCR-like antibody to an intracellular WT1 oncogene peptide compared with the tyrosine kinase inhibitor imatinib in a mouse model of Philadelphia chromosome positive (Ph+) ALL. Journal of Clinical Oncology. 31: 3047-3047
Dubrovsky L, Brea E, Pankov D, et al. (2013) Therapeutic Efficacy and Cure Of Sensitive and T315I Pan-Resistant Human Ph+ Leukemia In Mice Using a TCR-Like Antibody To WT1/HLA-A0201 Alone, Or In Combination With Tyrosine Kinase Inhibitors Blood. 122: 855-855
Pankov D, Dao T, Wang Y, et al. (2013) A Bi-Specific T Cell Engaging Monoclonal Antibody (mAb) Derived From a TCR-Like Mab Specific For WT1/HLA-A0201 (ESK-BiTE) Shows a Potent Activity Against Human AML and Ph+ ALL In Mouse Models Blood. 122: 2521-2521
Tseng HM, Shum D, Bhinder B, et al. (2012) A high-throughput scintillation proximity-based assay for human DNA ligase IV. Assay and Drug Development Technologies. 10: 235-49
Veomett N, Dao T, Pankov D, et al. (2012) Native and Fc Enhanced Therapeutic Human Monoclonal Antibodies Targeting the Intracellular WT1 Oncogene Product in Leukemia. Blood. 120: 2599-2599
See more...